Cell Cycle Activation Linked to Neuronal Cell Death Initiated by DNA Damage

Neuron

Volumn 41, Issue 4, 2004, Pages 549-561

  Kruman, Inna I ^a,d   Wersto, Robert P ^a   Cardozo Pelaez, Fernando ^b   Smilenov, Lubomir ^c   Chan, Sic L ^a   Chrest, Francis J ^a   Emokpae Jr , Roland ^a   Gorospe, Myriam ^a   Mattson, Mark P ^a,e  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b UNIVERSITY OF MONTANA   (United States)

^c School of Medicine ^*  (United States)

^d SUN HEALTH RESEARCH INSTITUTE   (United States)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATM PROTEIN; COLCHICINE; ETOPOSIDE; HOMOCYSTEINE; METHOTREXATE; STAUROSPORINE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ATTENUATION; BRAIN CELL; CELL CYCLE; CONTROLLED STUDY; DNA DAMAGE; EMBRYO; FEMALE; GENOTOXICITY; MALE; MITOSIS; MOUSE; NERVE CELL DIFFERENTIATION; NERVE CELL NECROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT;

EID: 1342333775     PISSN: 08966273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0896-6273(04)00017-0     Document Type: Article

References (80)

1. Adamec E., Vonsattel J.P., Nixon R.A. DNA strand breaks in Alzheimer's disease. Brain Res. 849:1999;67-77.
2. Almong N., Rotter V. Involvement of p53 in cell differentiation and development. Biochim. Biophys. Acta. 1333:1997;F1-F27.
3. Barlow C., Hirotsune S., Paylor R., Liyanage M., Eckhaus M., Collins F., Shiloh Y., Crawley J.N., Ried T., Tagle D., Wynshaw-Boris A. Atm-deficient mice. a paradigm of ataxia telangiectasia Cell. 86:1996;159-171.
4. Beck W.T., Mo Y.Y., Bhat U.G. Cytotoxic signaling by inhibitors of DNA topoisomerase II. Biochem. Soc. Trans. 29:2001;702-703.
5. Blasina A., Price B.D., Turenne G.A., McGowan C.H. Caffeine inhibits the checkpoint kinase ATM. Curr. Biol. 9:1999;1135-1138.
6. Blomberg I., Hoffmann I. Ectopic expression of Cdc25A accelerates the G1/S transition and leads to premature activation of cyclin E- and cyclin A-dependent kinases. Mol. Cell. Biol. 19:1999;6183-6194.
7. Blount B.C., Mack M.M., Wehr C.M., MacGregor J.T., Hiatt R.A., Wang G., Wickramasinghe S.N., Everson R.B., Ames B.N. Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage. implication for cancer and neuronal damage Proc. Natl. Acad. Sci. USA. 94:1997;3290-3295.
8. Borchelt D.R., Thinakaran G., Eckman C.B., Lee M.K., Davenport F., Ratovitsky T., Prada C.M., Kim G., Seekins S., Yager D.et al. Familial Alzheimer's disease-linked presenilin 1 variants elevate Abeta1-42/1-40 ratio in vitro and in vivo. Neuron. 17:1996;1005-1013.
9. Cangi M.G., Cukor B., Soung P., Signoretti S., Moreira G. Jr., Ranashinge M., Cady B., Pagano M., Loda M. Role of the Cdc25A phosphatase in human breast cancer. J. Clin. Invest. 106:2000;753-761.
10. Cardozo-Pelaez F., Song S., Parthasarathy A., Epstein C.J., Sanchez-Ramos J. Attenuation of age-dependent oxidative damage to DNA and protein in brainstem of Tg Cu/Zn SOD mice. Neurobiol. Aging. 19:1998;311-316.
11. Cardozo-Pelaez F., Brooks P.J., Stedeford T., Song S., Sanchez-Ramos J.R. DNA damage, repair, and autooxidant systems. a correlative study Free Radic. Biol. Med. 28:2000;779-785.
12. Choi E.K., Lee Y.H., Choi Y.S., Kwon H.M., Choi M.S., Ro J.Y., Park S.K., Yu E. Heterogenous expression of Ku70 in human tissues is associated with morphological and functional alterations of the nucleus. J. Pathol. 198:2002;121-130.
13. Chong M.J., Murray M.R., Gosink E.C., Russell H.R., Srinivasan A., Kapsetaki M., Korsmeyer S.J., McKinnon P.J. Atm and Bax cooperate in ionizing radiation-induced apoptosis in the central nervous system. Proc. Natl. Acad. Sci. USA. 97:2000;889-894.
14. Copani A., Condorelli F., Caruso A., Vancheri C., Sala A., Giuffrida Stella A.M., Canonico P.L., Nicoletti F., Sortino M.A. Mitotic signaling by β-amyloid causes neuronal death. FASEB J. 13:1999;2225-2234.
15. Copani A., Uberti D., Sortino M.A., Bruno V., Nicoletti F., Memo M. Activation of cell-cycle-associated proteins in neuronal death. a mandatory or dispensable path? Trends Neurosci. 24:2001;25-31.
16. Cooper-Kuhn C.M., Kuhn H.G. Is it all DNA repair? Methodological considerations for detecting neurogenesis in the adult brain. Brain Res. Dev. Brain Res. 134:2002;13-21.
17. Cornforth M.N., Bedford J.S. On the nature of a defect in cells from individuals with ataxia-telangiectasia. Science. 227:1985;1589-1591.
18. Culmsee C., Zhu X., Yu Q.S., Chan S.L., Camandola S., Guo Z., Greig N.H., Mattson M.P. A synthetic inhibitor of p53 protects neurons against death induced by ischemic and excitotoxic insults, and amyloid beta-peptide. J. Neurochem. 77:2001;220-228.
19. Ding X.L., Husseman J., Tomashevski A., Nochlin D., Jin L.W., Vincent I. The cell cycle Cdc25A tyrosine phosphatase is activated in degenerating postmitotic neurons in Alzheimer's disease. Am. J. Pathol. 157:2000;1983-1990.
20. Donzelli D., Squatrito M., Ganoth D., Hershko A., Pagano M., Draetta F. Dual mode of degradation of Cdc25A phosphatase. EMBO J. 21:2002;4875-4884.
21. Fezoui Y., Hartley D.M., Walsh D.M., Selkoe D.J., Osterhout J.J., Teplow D.B. A de novo designed helix-turn-helix peptide forms nontoxic amyloid fibrils. Nat. Struct. Biol. 7:2000;1095-1099.
22. Frosina G., Fortini P., Rossi O., Carrozzino F., Raspaglio G., Cox L.S., Lane D.P., Abbondandolo A., Dogliotti E. Two pathways for base excision repair in mammalian cells. J. Biol. Chem. 271:1996;9573-9578.
23. Gabbita S.P., Lovell M.A., Markesbery W.R. Increased nuclear DNA oxidation in the brain in Alzheimer's disease. J. Neurochem. 71:1998;2034-2040.
24. Galaktionov K., Beach D. Specific activation of cdc25 tyrosine phosphatases by B-type cyclins. evidence for multiple roles of mitotic cyclins Cell. 67:1991;1181-1194.
25. Galaktionov K., Chen X., Beach D. Cdc25 cell-cycle phosphatase as a target of c-myc. Nature. 382:1996;511-517.
26. Gobbel G.T., Bellinzona M., Vogt A.R., Gupta N., Fike J.R., Chan P.H. Response of postmitotic neurons to X-irradiation. implications for the role of DNA damage in neuronal apoptosis J. Neurosci. 18:1998;147-155.
27. Gorman A.M., Bonfoco E., Zhivotovsky B., Orrenius S., Ceccatelli S. Cytochrome c release and caspase-3 activation during colchicines-induced apoptosis of cerebellar granule neurons. Eur. J. Neurosci. 11:1999;1067-1072.
28. Gulian M., Bleile B., Tseng B.Y. Methotrexate-induced misincorporation of uracil into DNA. Proc. Natl. Acad. Sci. USA. 77:1980;1956-1960.
29. Hanawalt P.C., Gee P., Ho L., Hsu R.K., Kane C.J. Genomic heterogeneity of DNA repair. Role in aging? Ann. N Y Acad. Sci. 663:1992;17-25.
30. Hayashi T., Sakai K., Sasaki C., Zhang W.R., Abe K. Phosphorylation of retinoblastoma protein in rat brain after transient middle cerebral artery occlusion. Neuropathol. Appl. Neurobiol. 26:2000;390-397.
31. Herzog K.H., Kapsetaki M., Morgan J.I., McKinnon P.J. Requirement for ATM in ionizing radiation-induced cell death in the developing central nervous system. Science. 280:1998;1089-1091.
32. Hoffmann I., Draetta G., Karsenti E. Activation of the phosphatase activity of human cdc25A by a cdk2-cyclin E dependent phosphorylation at the G1/S transition. EMBO J. 13:1994;4302-4310.
33. Huschtscha L.I., Jeitner T.M., Andersson C.E., Bartier W.A., Tattersall M.H. Identification of apoptotic and necrotic human leukemic cells by flow cytometry. Exp. Cell Res. 212:1994;161-165.
34. Husseman J.W., Nochlin D., Vincent I. Mitotic activation. A convergent mechanism for a cohort of neurodegenerative disease Neurobiol. Aging. 21:2000;815-828.
35. Katchanov J., Harms C., Gertz K., Hauck L., Warber C., Hirt L., Priller J., von Harsdorf R., Bruck W., Hortnagl H.et al. Mild cerebral ischemia induces loss of cyclin-dependent kinase inhibitors and activation of cell cycle machinery before delayed neuronal cell death. J. Neurosci. 21:2001;5045-5053.
36. Kruman I., Bruce-Keller A.J., Bredesen D., Waeg G., Mattson M.P. Evidence that 4-hydroxynonenal mediates oxidative stress-induced neuronal apoptosis. J. Neurosci. 17:1997;5089-5100.
37. Kruman I.I., Culmsee C., Chan S.L., Kruman Y., Guo Z., Penix L., Mattson M.P. Homocysteine elicits a DNA damage response in neurons that promotes apoptosis and hypersensitivity to excitotoxicity. J. Neurosci. 20:2000;6920-6926.
38. Kruman I.I., Kumaravel T.S., Lohani A., Pedersen W.A., Cutler R.G., Kruman Y., Haughey N., Lee J., Evans M., Mattson M.P. Folic acid deficiency and homocysteine impair DNA repair in hippocampal neurons and sensitize them to amyloid toxicity in experimental models of Alzheimer's disease. J. Neurosci. 22:2002;1752-1762.
39. Li X., Melamed M.R., Darzynkievicz Z. Detection of apoptosis and DNA replication by different labeling of DNA strand breaks with fluorochromes of different color. Exp. Cell Res. 222:1996;28-37.
40. Liu D.X., Greene L.A. Neuronal apoptosis at the G1/S cell cycle checkpoint. Cell Tissue Res. 305:2001;217-228.
41. Lovell M.A., Gabbita S.P., Markesbery W.R. Increased DNA oxidation and decreased levels of repair products in Alzheimer's disease ventricular CSF. J. Neurochem. 72:1999;771-776.
42. Macleod M.R., Ramage L., McGregor A., Seck J.R. Reduced NMDA-induced apoptosis in neurons lacking ataxia telangiectasia mutated protein. Neuroreport. 14:2003;215-217.
43. Mattson M.P. Apoptosis in neurodegenerative disorders. Nat. Rev. Mol. Cell Biol. 1:2000;20-29.
44. Mattson M.P., Tomaselli K.J., Rydel R.E. Calcium-destabilizing and neurodegenerative effects of aggregated beta-amyloid peptide are attenuated by basic FGF. Brain Res. 621:1993;35-49.
45. McCombe P., Lavin M., Kidson C. Control of DNA repair linked to neuroblastoma differentiation. Int. J. Radiat. Biol. Relat. Stud. Phys. Chem. Med. 29:1976;523-531.
46. McShea A., Wahl A.F., Smith M.A. Re-entry into the cell cycle. a mechanism for neurodegeneration in Alzheimer disease Med. Hypotheses. 52:1999;525-527.
47. Morris E.J., Geller H.M. Induction of neuronal apoptosis by camptothecin, an inhibitor of DNA topoisomerase-I. evidence for cell cycle-independent toxicity J. Cell Biol. 134:1996;757-770.
48. Morris E.J., Dreixler J.C., Cheng K.Y., Wilson P.M., Gin R.M., Geller H.M. Optimization of single-cell gel electrophoresis (SCGE) for quantitative analysis of neuronal DNA damage. Biotechniques. 26:1999;286-289.
49. Nagayama T., Lan J., Henshall D.C., Chen D., O'Horo C., Simon R.P., Chen J. Induction of oxidative DNA damage in the peri-infarct region after permanent focal cerebral ischemia. J. Neurochem. 75:2000;1716-1728.
50. Nagelhus T.A., Haug T., Singh K.K., Keshav K.F., Skorpen F., Otterlei M., Bharati S., Lindmo T., Benichou S., Benarous R., Krokan H.E. A sequence in the N-terminal region of human uracil-DNA glycosylase with homology to XPA interacts with the C-terminal part of the 34-kDa subunit of replication protein A. J. Biol. Chem. 272:1997;6561-6566.
51. Nagy Z., Esiri M.M., Smith A.D. The cell division cycle and the pathophysiology of Alzheimer's disease. Neuroscience. 87:1998;731-739.
52. Neugroschl J., Davis K.L. Biological Markers in Alzheimer Disease. Am. J. Geriatr. Psychiatry. 10:2003;660-677.
53. Ninomiya Y., Adams R., Morris-Kay G.M., Eto K. Apoptotic cell death in neuronal differentiation of P19EC cells. cell death follows reentry into S phase J. Cell. Physiol. 172:1997;25-35.
54. Nouspikel T., Hanawalt P.C. Terminally differentiated human neurons repair transcribed genes but display attenuated global DNA repair and modulation of repair gene expression. Mol. Cell. Biol. 20:2000;1562-1570.
55. Otterlei M., Warbrick E., Nagelhus T.A., Haug T., Slupphaug G., Akbari M., Aas P.A., Steinsbekk K., Bakke O., Krokan H.E. Post-replicative base excision repair in replication foci. EMBO J. 18:1999;3834-3844.
56. Park D.S., Levine B., Ferrari G., Greene L. Cyclin dependent kinase inhibitors and dominant negative cyclin dependent kinase 4 and 6 promote survival of NGF-deprived sympathetic neurons. J. Neurosci. 17:1997;8975-8983.
57. Park D.S., Morris E.J., Padmanabhan J., Shelanski M.I., Geller H.M., Greene L.A. Cyclin-dependent kinases participate in death of neurons evoked by DNA-damaging agents. J. Cell Biol. 143:1998;457-467.
58. Rhind N., Russell P. Checkpoints. it takes more than time to heal some wounds Curr. Biol. 10:2000;R908-R911.
59. Rideout H.J., Wang Q., Park D.S., Stefanis L. Cyclin-dependent kinase activity is required for apoptotic death but not inclusion formation in cortical neurons after proteasomal inhibition. J. Neurosci. 23:2003;1237-1245.
60. Rolig R.L., McKinnon P.J. Linking DNA damage and neurodegeneration. Trends Neurosci. 23:2000;417-424.
61. Roser S., Pool-Zobel B.L., Rechkemmer G. Contribution of apoptosis to responses in the comet assay. Mutat. Res. 497:2001;169-175.
62. Rotman G., Shiloh Y. Atm. from gene to function Hum. Mol. Genet. 7:1998;1555-1563.
63. Ruggiero A., Conter V., Milani M., Biagi E., Lazzareschi I., Sparano P., Riccardi R. Intrathecal chemotherapy with antineoplastic agents in children. Paediatr. Drugs. 3:2001;237-246.
64. Sakakura C., Koide K., Shirasu M., Ichikawa D., Wasaka M., Ogaki M., Yamazaki J., Inazawa J., Abe T., Taniguchi H.et al. Increased apoptosis rate by hyperthermochemoradiotherapy for advanced rectal cancers. Surg. Today. 27:1997;773-776.
65. Sarkaria J.N., Busby E.C., Tibbetts R.S., Roos P., Taya Y., Karnitz L.M., Abraham R.T. Inhibition of ATM and ATR kinase by the radiosensitizing agent, caffeine. Cancer Res. 59:1999;4375-4382.
66. Savitsky K., Bar-Shira A., Gilad S., Rotman G., Ziv Y., Vanagaite L., Tagle D.A., Smith S., Uziel T., Sfez S. A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science. 268:1995;1749-1753.
67. Savitsky K., Bar-Shira A., Gilad S., Rotman G., Ziv Y., Vanagaite L., Tagle D.A., Sexl V., Diehl J.A., Sherr C.J.et al. A rate limiting function of cdc25A for S phase entry inversely correlates with tyrosine dephosphorylation of Cdk2. Oncogene. 18:1999;573-582.
68. Shiloh Y., Kastan M.B. Atm. genome stability, neuronal development, and cancer cross paths Adv. Cancer Res. 83:2001;209-254.
69. Smith M.Z., Nagy Z., Esiri M.M. Cell cycle-related protein expression in vascular dementia and Alzheimer's disease. Neuroreport. 271:1999;45-48.
70. Smith D.S., Leone G., DeGregori J., Ahmed M.N., Qumsiyeh M.B., Nevins J.R. Induction of DNA replication in adult rat neurons by deregulation of the retinoblastoma/E2F G1 cell cycle pathway. Cell Growth Differ. 11:2000;625-633.
71. Smith N.D., Rubenstein J.N., Eggener S.E., Kozlowski J.M. The p53 tumor suppressor gene and nuclear protein. basic science review and relevance in the management of bladder cancer J. Urol. 169:2003;1219-1228.
72. Stedeford T., Cardozo-Pelaez F., Nemeth N., Song S., Harbison R.D., Sanchez-Ramos J. Comparison of base-excision repair capacity in proliferating and differentiated PC 12 cells following acute challenge with dieldrin. Free Radic. Biol. Med. 31:2001;1272-1278.
73. Uberti D., Ferrari Toninelli G., Memo M. Involvement of DNA damage and repair systems in neurodegenerative process. Toxicol. Lett. 139:2003;99-105.
74. Uppuluri S., Knipling L., Sackett D.L., Wolff J. Localization of the colchicine-binding site of tubulin. Proc. Natl. Acad. Sci. USA. 90:1993;11598-11602.
75. Van Triest B., Pinedo H.M., Giaccone G., Peters G.J. Downstream molecular determinants of response to 5-fluorouracil and antifolate thymidylate synthase inhibitors. Ann. Oncol. 11:2000;385-391.
76. Virag L., Szabo C. The therapeutic potential of poly(ADP-ribose) polymerase inhibitors. Pharmacol. Rev. 54:2002;375-429.
77. Wallace S.S. Oxidative damage to DNA and its repair. Scandalios J.G. Oxidative Stress and the Molecular Biology of Antioxidant Defences. 1997;49-89 Cold Spring Harbor Laboratory, Cold Spring Harbor, New York.
78. Walsh M.J., Shue G., Spidoni K., Kapoor A. E2F-1 and a cyclin-like DNA repair enzyme, uracil-DNA glycosylase, provide evidence for an autoregulatory mechanism for transcription. J. Biol. Chem. 270:1995;5289-5298.
79. Yamasaki F., Hama S., Yoshioka H., Kajiwara Y., Yahara K., Sugiyama K., Heike Y., Arita K., Kurisu K. Staurosporine-induced apoptosis is independent of p16 and p21 and achieved via arrest at G2/M and at G1 in U251MG human glioma cell line. Cancer Chemother. Pharmacol. 51:2003;271-283.
80. Yang Y., Geldmacher D.S., Herrup K. DNA replication precedes neuronal cell death in Alzheimer's disease. J. Neurosci. 21:2001;2661-2668.